RFA R-Evolution: a New Protocol to Avoid Implant Failure

Launched by DANIELE MORETTO · Jan 28, 2025

Keywords

ClinConnect Summary

The RFA R-Evolution trial is studying dental implants to find out how different factors—like the position of the implant, the patient's medical history, and lifestyle choices such as smoking—can affect the stability of these implants over time. The researchers will measure something called the Implant Stability Quotient (ISQ) at various points during the first year after the implants are placed. This information will help doctors decide the best time to put pressure on the implants, which is crucial for their long-term success.

To participate in this study, you need to have received a specific type of dental implant (NobelReplace, NobelActive, or NobelParallel) after October 2021, and you must be at least 18 years old. You should also be willing to return for a follow-up visit at least one year after your surgery, where your implant's stability will be checked multiple times. It's important to know that this trial is not yet recruiting participants, so you would need to wait until it officially begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participant received implant treatment NobelReplace, NobelActive or NobelParallel implants on or after October 2021 (with TiUnite or TiUltra surfaces)
• • Participant was at least 18 years old at the time of surgery
• • Participant attended a follow-up visit at least 1-year after surgery
• • Implant stability was assessed by means of RFA at a minimum of three time-points
• Exclusion Criteria:
• • 1-year follow-up data not available
• • Subject received major guided bone regeneration